Zentalis Pharmaceuticals, Inc. Insider Trading for April 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Zentalis Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Zentalis Pharmaceuticals, Inc. for April 2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 14 2021 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 45.00 | 3,810 | 171,450 | 50,520 | 54.3 K to 50.5 K (-7.01 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 45.06 | 33 | 1,487 | 535,573 | 535.6 K to 535.6 K (-0.01 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 44.21 | 58 | 2,564 | 535,606 | 535.7 K to 535.6 K (-0.01 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 43.37 | 5,399 | 234,131 | 535,664 | 541.1 K to 535.7 K (-1.00 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 43.26 | 165 | 7,138 | 541,063 | 541.2 K to 541.1 K (-0.03 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Gallagher Cam | Director | Sell | S | 43.41 | 22,714 | 985,917 | 541,228 | 563.9 K to 541.2 K (-4.03 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 45.06 | 83 | 3,740 | 266,323 | 266.4 K to 266.3 K (-0.03 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 44.21 | 149 | 6,588 | 266,406 | 266.6 K to 266.4 K (-0.06 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 43.37 | 13,792 | 598,100 | 266,555 | 280.3 K to 266.6 K (-4.92 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Epperly Melissa B, | Chief Financial Off ... | Sell | S | 43.43 | 3,083 | 133,896 | 280,347 | 283.4 K to 280.3 K (-1.09 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 45.07 | 400 | 18,028 | 54,330 | 54.7 K to 54.3 K (-0.73 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 43.26 | 275 | 11,897 | 1,019,653 | 1 M to 1 M (-0.03 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 43.36 | 15,361 | 666,053 | 1,019,928 | 1 M to 1 M (-1.48 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 45.06 | 54 | 2,433 | 1,035,289 | 1 M to 1 M (-0.01 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 44.21 | 97 | 4,289 | 1,035,343 | 1 M to 1 M (-0.01 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 43.37 | 9,024 | 391,332 | 1,035,440 | 1 M to 1 M (-0.86 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 45.06 | 224 | 10,094 | 1,702,811 | 1.7 M to 1.7 M (-0.01 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 44.21 | 400 | 17,686 | 1,703,035 | 1.7 M to 1.7 M (-0.02 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 43.37 | 37,144 | 1,610,776 | 1,703,435 | 1.7 M to 1.7 M (-2.13 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 45.06 | 600 | 27,033 | 1,740,579 | 1.7 M to 1.7 M (-0.03 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 44.25 | 2,300 | 101,773 | 1,741,179 | 1.7 M to 1.7 M (-0.13 %) |
Apr 06 2021 | ZNTL | Zentalis Pharmaceu ... | SUN ANTHONY Y | President & CEO | Sell | S | 43.38 | 23,894 | 1,036,438 | 1,743,479 | 1.8 M to 1.7 M (-1.35 %) |
Apr 05 2021 | ZNTL | Zentalis Pharmaceu ... | Johnson David Michael | Director | Sell | S | 43.50 | 12,897 | 561,021 | 88,855 | 101.8 K to 88.9 K (-12.67 %) |
Apr 05 2021 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 44.90 | 100 | 4,490 | 54,730 | 54.8 K to 54.7 K (-0.18 %) |
Apr 05 2021 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 43.88 | 1,674 | 73,449 | 54,830 | 56.5 K to 54.8 K (-2.96 %) |
Apr 05 2021 | ZNTL | Zentalis Pharmaceu ... | Bunker Kevin D. | Chief Operating Off ... | Sell | S | 43.09 | 2,436 | 104,978 | 56,504 | 58.9 K to 56.5 K (-4.13 %) |